Navigation Links
ANAVEX reports sigma receptor review published in leading journal
Date:8/27/2009

GENEVA, Switzerland, Aug. 27 /PRNewswire-FirstCall/ - Anavex Life Sciences Corp. ("ANAVEX" or the "Company") (OTCBB: AVXL) reports the publication of a comprehensive review of the pharmacology of sigma receptors and their possible clinical application in the peer-reviewed Journal of Pharmacology Therapeutics.

The paper provides new insight into sigma-1 receptors and their potential ability to alter the course of Alzheimer's disease, other CNS conditions and cancer. In their review, leading scientists Dr. Tangui Maurice and Dr. Tsung-Ping Su emphasize that sigma-1 receptors effect the modulation of various ion channels, including calcium, potassium, sodium and chloride ions, which allow atoms to enter or leave a cell and change its behavior. Further work may show the impact on mitochondria, a cell's principal energy source. Dysfunction in the mitochondria is a known contributor to neurodegenerative diseases such as Alzheimer's and a wide range of other diseases. ANAVEX believes that mitochondrial dysfunction can be modified using sigma receptors to guard against oxidative stress, which damages and destroys neurons and is believed to be a primary cause of Alzheimer's disease.

"This review sheds new light on the field of sigma receptors," said Dr. Herve de Kergrohen, CEO of ANAVEX. "ANAVEX is pleased that academic leaders are communicating the hope that this new understanding of mechanisms of action in the field of sigma receptors could bring to a range of conditions. This is particularly relevant to Alzheimer's patients, their families and caregivers."

ANAVEX is the leader in the discovery and development of new drugs that specifically target sigma receptors. The company's lead compound for Alzheimer's disease, ANAVEX 2-73, is being prepared to enter clinical trials in 2010. ANAVEX 2-73 is a selective sigma-1 receptor agonist (Vamvakides, 2002; Espallergues et al., 2007) and has demonstrated potent neuroprotective, anti-amnesic, anti-c
'/>"/>

SOURCE Anavex Life Sciences Corp.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Cumberland Pharmaceuticals Reports Second Quarter 2009 Financial Results
2. Consumer Reports Health News - August 2009
3. FDA Investigating Weight-Loss Drug Over Reports of Liver Damage
4. China Nepstar Chain Drugstore Reports Second Quarter 2009 Financial Results
5. STAAR Surgical Reports Progress on Japanese Application for Approval of Visian(TM) Implantable Collamer(R) Lens (ICL(TM))
6. Weikang Bio-Technology Group Co., Inc. Reports Record Second Quarter Results
7. Cyberonics Reports Strong Fiscal 2010 First Quarter Results
8. Neovasc Inc. Reports Second Quarter 2009 Financial Results
9. Sinovac Reports Unaudited Second Quarter 2009 Financial Results
10. Lilly Reports on Outcome of Phase III Study of Arzoxifene
11. Perrigo Reports Record Sales, Earnings and Cash Flow From Operations for Fiscal 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/25/2014)... 25, 2014 The global HCIT outsourcing ... 7.6%, to reach $50.4 billion by 2018 from $35 ... industry, and pharmaceutical industry are driving the HCIT outsourcing ... enhance their focus on core business, reduce operational and ... staff (further reducing hiring and training costs), share risk, ...
(Date:10/25/2014)... 2014 Background: , In 1998 Bob ... is a pioneer in the field of establishing recovery community ... treatment system and when he retired, he set out to ... public service. , 1. Where are the ... them? , 2. Can the recovery community be organized ...
(Date:10/25/2014)... TX (PRWEB) October 25, 2014 ... Chinese Molecular Diagnostics Industry, 2009-2019 is a ... and Chinese Molecular Diagnostics industry. The report ... Diagnostics including its classification, application and manufacturing ... China’s top manufacturers of Molecular Diagnostics listing ...
(Date:10/25/2014)... York, New York (PRWEB) October 25, 2014 ... transvaginal mesh lawsuits ( http://www.vaginalmeshlawsuit2015.com/ ) filed ... litigation underway in U.S. District Court, Southern District ... for Summary Judgment on Punitive Damages in a ... plaintiffs. In a ruling issued on October 21st, ...
(Date:10/25/2014)... blood supply to an arm or a leg before heart ... according to a new study. "During heart surgery ... to be able to operate on it. After some time ... produce energy because it doesn,t get oxygen. When we shut ... an arm or a leg, the body prepares for an ...
Breaking Medicine News(10 mins):Health News:Global HCIT Outsourcing Market to Grow at 7.6% CAGR to 2018 Says a Premium Research Report Available at ReportsnReports.com 2Health News:Global HCIT Outsourcing Market to Grow at 7.6% CAGR to 2018 Says a Premium Research Report Available at ReportsnReports.com 3Health News:Global HCIT Outsourcing Market to Grow at 7.6% CAGR to 2018 Says a Premium Research Report Available at ReportsnReports.com 4Health News:CCAR Accepting Nominations for the Bob Savage Recovery Advocate of the Year Award 2Health News:Global and China Molecular Diagnostics Industry Analysis to 2019 is Now Available at RnRMarketResearch.com 2Health News:Global and China Molecular Diagnostics Industry Analysis to 2019 is Now Available at RnRMarketResearch.com 3Health News:Global and China Molecular Diagnostics Industry Analysis to 2019 is Now Available at RnRMarketResearch.com 4Health News:Transvaginal Mesh Lawsuits Move Forward, As Federal Judge Denies Motion for Summary Judgment on Punitive Damages in Florida Cases, Bernstein Liebhard LLP Reports 2Health News:Transvaginal Mesh Lawsuits Move Forward, As Federal Judge Denies Motion for Summary Judgment on Punitive Damages in Florida Cases, Bernstein Liebhard LLP Reports 3Health News:Transvaginal Mesh Lawsuits Move Forward, As Federal Judge Denies Motion for Summary Judgment on Punitive Damages in Florida Cases, Bernstein Liebhard LLP Reports 4Health News:Brief Interruption of Blood Supply to Limb Might Aid Heart Surgery: Study 2
... 13 The National Council on,Disability (NCD) will release ... Care System: Barriers to Success and Proposed,Policy Solutions, at ... at,the U.S. Department of Health and Human Services, 200 ... open to the public and the,media and free of ...
... CINCINNATI, Feb. 13, 2008 The Procter & Gamble Company,(NYSE: PG ... J. Johnson, 61, chief legal officer, will retire on June 1, 2008 ... Steven W. Jemison, 56, currently deputy general counsel, will succeed ... John P. Goodwin, 44, currently vice president - finance and ...
... been chosen as a NEO Success Award Winner for ... row that Antares has won this,prestigious award., Since ... top,public, private and emerging companies by revenue and employment. ... of business to,Northeast Ohio,s economic vitality., "Winning the ...
... R.I. - Screening all emergency room patients for carbon ... that can be done even in a high-volume urban ... Rhode Island Hospital. , In the largest study of ... emergency department were routinely screened for exposure to carbon ...
... system for tracking the movement of,the prostate during ... Seattle,Cancer Care Alliance. Featuring tiny GPS-type positioning transponders,implanted ... of the,prostate in real time and alerts technicians ... can adjust the external beam of,radiation., The ...
... editors of the Proceedings of the National Academy of ... the 2007 Cozzarelli Prize, an award for papers that ... , The award was established in 2005 as the ... Cozzarelli Prize in 2007 to honor late PNAS Editor-in-Chief ...
Cached Medicine News:Health News:National Council on Disability to Make Recommendations on Youth with Disabilities in the Foster Care System 2Health News:Procter & Gamble Announces Organizational Changes 2Health News:Antares Management Solutions 2008 NEO Success Award Winner 2Health News:Routine screenings uncover hidden carbon monoxide poisoning 2Health News:Routine screenings uncover hidden carbon monoxide poisoning 3Health News:GPS for the Prostate: System Keeps Radiation Therapy on Target 2Health News:PNAS announces 2007 Cozzarelli Prize recipients 2
(Date:10/22/2014)... Investor-Edge has initiated coverage on the following ... Progenics Pharmaceuticals Inc. (NASDAQ: PGNX ), Threshold ... Inc. (NASDAQ: IDRA ), and Merrimack Pharmaceuticals ... can be accessed at: http://investor-edge.com/register . ... at 4,419.48, up 2.40%, the Dow Jones Industrial Average ...
(Date:10/22/2014)... Vernak, RPh, of Vernak Farms Pharmacy in ... George Roentsch Scholarship by the Professional Compounding Centers of ... Houston during PCCA,s International Seminar, held October ... independent pharmacist and PCCA member who embodies the innovative ... well-known pharmacist in the compounding community. ...
(Date:10/22/2014)... Moms are ready to live the "measured ... their kids, according to the results of the BabyCenter® ... Mobile for Moms, the latest installment in BabyCenter,s 21 ... pregnancy and parenting web and mobile destination worldwide, conducted ... surveyed say they can,t think of a reason not ...
Breaking Medicine Technology:Market Momentum on Biotech Stocks - Amicus Therapeutics, Progenics Pharma, Threshold Pharma, Idera Pharma, and Merrimack Pharma 2Market Momentum on Biotech Stocks - Amicus Therapeutics, Progenics Pharma, Threshold Pharma, Idera Pharma, and Merrimack Pharma 3Market Momentum on Biotech Stocks - Amicus Therapeutics, Progenics Pharma, Threshold Pharma, Idera Pharma, and Merrimack Pharma 4Market Momentum on Biotech Stocks - Amicus Therapeutics, Progenics Pharma, Threshold Pharma, Idera Pharma, and Merrimack Pharma 5PCCA Awards Charlene Vernak, RPh, the George Roentsch Scholarship 2BabyCenter Finds Mom Ready to Live the "Measured Life" in its U.S. Mobile Mom 2014 Report: Health & Fitness Go Mobile for Moms 2BabyCenter Finds Mom Ready to Live the "Measured Life" in its U.S. Mobile Mom 2014 Report: Health & Fitness Go Mobile for Moms 3BabyCenter Finds Mom Ready to Live the "Measured Life" in its U.S. Mobile Mom 2014 Report: Health & Fitness Go Mobile for Moms 4
... , ALEXANDRIA, Va. , May 6 The National ... Reform and Transparency Act of 2010 , which would aim to ... managers (PBM) -- the largely unaccountable giant prescription drug plan administrators, ... Inc. , , , ...
... The U.S. Food and Drug Administration today approved Natazia, a combination hormonal ... , , ... , , ... and is the first four-phasic oral contraceptive marketed in the United States ...
Cached Medicine Technology:NCPA Applauds Rep. Weiner for Introducing Bill to Rein in Pharmacy Benefit Manager Practices That Hurt Patients, Plan Sponsors and Community Pharmacies 2NCPA Applauds Rep. Weiner for Introducing Bill to Rein in Pharmacy Benefit Manager Practices That Hurt Patients, Plan Sponsors and Community Pharmacies 3FDA Approves New Combination Product Oral Contraceptive 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: